Treatment of acute posterior uveitis in a porcine model by injection of triamcinolone acetonide into the suprachoroidal space using microneedles

Investigative Ophthalmology and Visual Science

Volumn 54, Issue 4, 2013, Pages 2483-2492

  Gilger, Brian C ^a   Abarca, Eva M ^a   Salmon, Jacklyn H ^a   Patel, Samirkumar ^b  

^a NORTH CAROLINA STATE UNIVERSITY   (United States)

^b Clearside Biomedical   (United States)

Author keywords

Drug delivery; Microneedle; Posterior segment; Suprachoroidal space; Uveitis

Indexed keywords

TRIAMCINOLONE; TRIESSENCE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL COUNT; CHOROID; CONTROLLED STUDY; DRUG ADMINISTRATION ROUTE; ELECTRORETINOGRAPHY; EYE INFLAMMATION; FEMALE; FUNDUS CAMERA; HISTOPATHOLOGY; INTRAOCULAR PRESSURE; MALE; MICRONEEDLE; NONHUMAN; OPTICAL COHERENCE TOMOGRAPHY; PRIORITY JOURNAL; SWINE; UVEITIS;

ACUTE DISEASE; ANIMALS; AQUEOUS HUMOR; CELL COUNT; CHOROID; DISEASE MODELS, ANIMAL; ELECTRORETINOGRAPHY; EXTRACELLULAR SPACE; EYE PROTEINS; FEMALE; GLUCOCORTICOIDS; INTRAOCULAR PRESSURE; INTRAVITREAL INJECTIONS; LEUKOCYTES; MALE; NEEDLES; SUS SCROFA; TOMOGRAPHY, OPTICAL COHERENCE; TRIAMCINOLONE ACETONIDE; UVEITIS, POSTERIOR; VITREOUS BODY;

EID: 84875946501     PISSN: 01460404     EISSN: 15525783     Source Type: Journal    
DOI: 10.1167/iovs.13-11747     Document Type: Article

References (30)

1. Melnikova I. Wet age-related macular degeneration. Nat Rev Drug Discov. 2005;4:711-712.
2. Heier JS, Brown D, Ciulla T, et al. Ranibizumab for choroidal neovascularization secondary to causes other than age-related macular degeneration: a phase I clinical trial. Ophthalmology. 2011;118:111-118.
3. Gritz DC, Wong IG. Incidence and prevalence of uveitis in Northern California; the Northern California Epidemiology of Uveitis Study. Ophthalmology. 2004;111:491-500; discussion 500.
4. Maurice DM. Drug delivery to the posterior segment from drops. Surv Ophthalmol. 2002;47:S41-S52.
5. Urtti A. Challenges and obstacles of ocular pharmacokinetics and drug delivery. Adv Drug Deliv Rev. 2006;58:1131-1135.
6. Montero JA, Ruiz-Moreno JM. Intravitreal inserts of steroids to treat diabetic macular edema. Curr Diabetes Rev. 2009;5:26-32.
7. Grover D, Li TJ, Chong CC. Intravitreal steroids for macular edema in diabetes. Cochrane Database Syst Rev. 2008;(1): CD005656.
8. Cunningham MA, Edelman JL, Kaushal S. Intravitreal steroids for macular edema: the past, the present, and the future. Surv Ophthalmol. 2008;53:139-149.
9. Ramchandran RS, Fekrat S, Stinnett SS, et al. Fluocinolone acetonide sustained drug delivery device for chronic central retinal vein occlusion: 12-month results. Am J Ophthalmol. 2008;146:285-291.
10. Mohammad DA, Sweet BV, Elner SG. Retisert: is the new advance in treatment of uveitis a good one? Ann Pharmacother. 2007;41:449-454.
11. Canakis C, Livir-Rallatos C, Zafirakis P, et al. Acute endophthalmitis following intravitreal triamcinolone acetonide injection. Am J Ophthalmol. 2004;137:1158-1159; author reply 1160-1151.
12. Moshfeghi DM, Kaiser PK, Scott IU, et al. Acute endophthalmitis following intravitreal triamcinolone acetonide injection. Am J Ophthalmol. 2003;136:791-796.
13. Sampat KM, Garg SJ. Complications of intravitreal injections. Curr Opin Ophthalmol. 2010;21:178-183.
14. Veritti D, Di Giulio A, Sarao V, et al. Drug safety evaluation of intravitreal triamcinolone acetonide. Expert Opin Drug Saf. 2012;11:331-340.
15. Jain N, Stinnett SS, Jaffe GJ. Prospective study of a fluocinolone acetonide implant for chronic macular edema from central retinal vein occlusion: thirty-six-month results. Ophthalmology. 2012;119:132-137.
16. Gilger BC, Salmon JH, Wilkie DA, et al. A novel bioerodible deep scleral lamellar cyclosporine implant for uveitis. Invest Ophthalmol Vis Sci. 2006;47:2596-2605.
17. Gilger BC, Wilkie DA, Clode AB, et al. Long-term outcome after implantation of a suprachoroidal cyclosporine drug delivery device in horses with recurrent uveitis. Vet Ophthalmol. 2010; 13:294-300.
18. Olsen TW, Feng X, Wabner K, et al. Cannulation of the suprachoroidal space: a novel drug delivery methodology to the posterior segment. Am J Ophthalmol. 2006;142:777-787.
19. Olsen TW, Feng X, Wabner K, et al. Pharmacokinetics of pars plana intravitreal injections versus microcannula suprachoroidal injections of bevacizumab in a porcine model. Invest Ophthalmol Vis Sci. 2011;52:4749-4756.
20. Tetz M, Rizzo S, Augustin AJ. Safety of submacular suprachoroidal drug administration via a microcatheter: retrospective analysis of European treatment results. Ophthalmologica. 2012;227:183-189.
21. Seiler GS, Salmon JH, Mantuo R, et al. Effect and distribution of contrast medium after injection into the anterior suprachoroidal space in ex vivo eyes. Invest Ophthalmol Vis Sci. 2011;52: 5730-5736.
22. Patel SR, Lin AS, Edelhauser HF, et al. Suprachoroidal drug delivery to the back of the eye using hollow microneedles. Pharm Res. 2011;28:166-176.
23. Patel SR, Berezovsky DE, McCarey BE, et al. Targeted administration into the suprachoroidal space using a microneedle for drug delivery to the posterior segment of the eye. Invest Ophthalmol Vis Sci. 2012;53:4433-4441.
24. Thompson JT. Cataract formation and other complications of intravitreal triamcinolone for macular edema. Am J Ophthalmol. 2006;141:629-637.
25. Hackett RB, McDonald TO. Ophthalmic toxicology and assessing ocular irritation. In: Marzulli FN, Maibach HI, eds. Dermatoxicology. 5th ed. Washington, DC: Hemisphere Publishing Corporation; 1996:299-305; 557-566.
26. Allen JB, McGahan MC, Ferrell JB, et al. Nitric oxide synthase inhibitors exert differential time-dependent effects on LPSinduced uveitis. Exp Eye Res. 1996;62:21-28.
27. Allen JB, McGahan MC, Ogawa Y, et al. Intravitreal transforming growth factor-beta 2 decreases cellular infiltration in endotoxin-induced ocular inflammation in rabbits. Curr Eye Res. 1996;15:95-103.
28. Fleisher L, Ferrell JB, McGahan M. Ocular inflammatory effects of intravitreally injected tumor necrosis factor-a and endotoxin. Inflammation. 1990;14:325-335.
29. Bill A. Conventional and uveo-scleral drainage of aqueous humour in the cynomolgus money (Macaca irus) at normal and high intraocular pressures. Exp Eye Res. 1966;5:45-54.
30. Toris CB, Pederson JE. Effect of intraocular pressure on uveoscleral outflow following cyclodialysis in the monkey eye. Invest Ophthalmol Vis Sci. 1985;26:1745-1749.